Blog


  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Megan Sullivan

The SEC Aims To Lighten Several Disclosure Obligations In Regulation S-K

Posted by Megan Sullivan on 02/14/2020

On January 30, 2020, the United States Securities and Exchange Commission ("SEC") proposed amendments to Regulation S-K that are intended to modernize, simplify, and enhance certain financial disclosure obligations imposed upon companies registered with the SEC. Based upon recommendations in the Report on Review of Disclosure Requirements ...

Read more

Raymond N. Barto

Executive at Generic Drug Manufacturer Indicted on Price-Fixing Charges

Posted by Raymond N. Barto on 02/13/2020

A federal grand jury indicted Ara Aprahamian, an executive at Taro Pharmaceutical Industries, for violating the antitrust laws and for lying to FBI investigators. Aprahamian is now the third executive charged in the DOJ's investigation into the generic drug industry, with the other two executives having already pled guilty. Two manufacturers, ...

Read more

Alex B. Heller

PROPOSED FEDERAL BUDGET WOULD TRANSFER THE AUTHORITY OF THE PCAOB TO THE SEC

Posted by Alex B. Heller on 02/13/2020

The Trump administration released its proposed fiscal year 2021 federal budget on February 10, 2020. Under the proposed budget, the authority of the Public Company Accounting Oversight Board ("PCAOB") would be transferred to the Securities and Exchange Commission ("SEC") beginning in 2022. According to the budget, this would eliminate the ...

Read more

Patrick J. Collopy

Third Circuit Protects Philly Workers from Improper Salary History Inquiries

Posted by Patrick J. Collopy on 02/13/2020

On February 6, 2020, the Third Circuit Court of Appeals, the highest federal court in Pennsylvania, upheld the constitutionality of a city ordinance prohibiting Philadelphia employers from asking job applicants about their salary histories. The Third Circuit determined that Philadelphia lawmakers relied on substantial evidence that banning ...

Read more

Nina Varindani

SEC Proposal to Modernize Shareholder Proposal Rule Met with Criticism

Posted by Nina Varindani on 02/11/2020

On November 5, 2019, the SEC announced two proposed rules, the first of which proposed amendments to its rules governing proxy voting advice businesses (the "Proxy Advisory Amendment") and the second of which proposed amendments to modernize the rule governing the process for submitting shareholder proposals to be included in a company's proxy ...

Read more

Alex Hartzband

Federal Courts Field Legal Challenges to California Law Expanding “Employee” Status

Posted by Alex Hartzband on 02/11/2020

2020 has already proven to be an exciting year for the California employment bar, with two recent, high-stakes challenges to new legislation signed into law by Governor Gavin Newsom. The new law, A.B. 5, codifies and expands upon the three-prong "ABC test" adopted by the California Supreme Court in its landmark Dynamex v. Lee decision. Rather ...

Read more

Richard W. Gonnello

Update: Disgraced Congressman Sentenced to 26 Months in Prison For Insider Trading

Posted by Richard W. Gonnello on 01/31/2020

After pleading guilty to insider trading charges in 2019, Ex-New York Congressman Christopher Collins ("Collins") was sentenced to 26 months in prison (and an additional one year of supervised probation) and ordered to pay a $200,000 fine. This sentence comes after Collins admitted that—while serving on the Board of Directors of Innate Immunotherapeutics ...

Read more

Dillon Hagius

The California Consumer Privacy Act Takes Effect

Posted by Dillon Hagius on 01/31/2020

After its adoption in 2018, the California Consumer Privacy Act ("CCPA") took effect on January 1, 2020. Like the General Data Protection Regulation ("GDPR"), which took effect in the European Union in 2018, "the CCPA creates new consumer rights relating to the access to, deletion of, and sharing of personal information that is collected by ...

Read more

Kristyn Fields

State AGs Oppose Pfizer’s Attempt to Exit Generic Price-Fixing Litigation

Posted by Kristyn Fields on 01/30/2020

On January 28, 2020, attorneys general for more than 40 states opposed defendant Pfizer Inc.'s motion to dismiss in the Generic Pharmaceuticals Pricing Antitrust Litigation, arguing that, contrary to Pfizer's position, the branded drugmaker cannot be separated from its generic subsidiary, Greenstone LLC, the company from which the allegations ...

Read more

Christopher M. Lash

Florida’s New Business Corporation Act Establishes the State as a “Demand Futility” State for Shareholder Derivative Actions

Posted by Christopher M. Lash on 01/28/2020

On January 1, 2020, the new Florida Business Corporation Act (the "Act") became effective. The Act contains provisions establishing Florida as a "demand futility" state in relation to shareholder derivative litigation. Specifically, the revised statute provides: A complaint in a proceeding brought in the right of a corporation must be verified ...

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania